498 related articles for article (PubMed ID: 185891)
1. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
2. Mass screening for breast disease. Results, problems, and expectations.
Schwartz GF; Feig SA; Libshitz HI; Patchefsky AS; Nerlinger RE; Wallace JD
Obstet Gynecol; 1976 Aug; 48(2):137-41. PubMed ID: 181701
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of minimal breast cancer: a pathologist's viewpoint.
Wirman JA
Crit Rev Oncol Hematol; 1985; 3(1):35-74. PubMed ID: 2990747
[TBL] [Abstract][Full Text] [Related]
4. Treatment and survival of female patients with nonpalpable breast carcinoma.
Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
[TBL] [Abstract][Full Text] [Related]
5. Implications of suspicious findings in breast cancer screening.
Lewis JD; Milbrath JR; Shaffer KA; Das Gupta TK
Arch Surg; 1975 Aug; 110(8):903-7. PubMed ID: 168837
[TBL] [Abstract][Full Text] [Related]
6. Thermography, mammography, and clinical examination in breast cancer screening. Review of 16,000 studies.
Feig SA; Shaber GS; Schwartz GF; Patchefsky A; Libshitz HI; Edeiken J; Nerlinger R; Curley RF; Wallace JD
Radiology; 1977 Jan; 122(1):123-7. PubMed ID: 830320
[TBL] [Abstract][Full Text] [Related]
7. Method of tumor detection influences disease-free survival of women with breast carcinoma.
Senie RT; Lesser M; Kinne DW; Rosen PP
Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
[TBL] [Abstract][Full Text] [Related]
8. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
9. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
10. Significance and staging of nonpalpable carcinomas of the breast.
Schwartz GF; Feig SA; Patchefsky AS
Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
[TBL] [Abstract][Full Text] [Related]
11. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
[TBL] [Abstract][Full Text] [Related]
12. Occult lesions of the breast.
Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
[TBL] [Abstract][Full Text] [Related]
13. Nonpalpable breast cancer: needle-localized biopsy for diagnosis and considerations for treatment.
Marrujo G; Jolly PC; Hall MH
Am J Surg; 1986 May; 151(5):599-602. PubMed ID: 3010754
[TBL] [Abstract][Full Text] [Related]
14. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
15. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
[TBL] [Abstract][Full Text] [Related]
16. The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma.
Kaplan C; Matallana R; Wallack MK
Am Surg; 1990 Jan; 56(1):40-2. PubMed ID: 2153010
[TBL] [Abstract][Full Text] [Related]
17. Intraductal carcinoma of the breast.
von Rueden DG; Wilson RE
Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
[TBL] [Abstract][Full Text] [Related]
18. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
19. The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.
Price ER; Keedy AW; Gidwaney R; Sickles EA; Joe BN
AJR Am J Roentgenol; 2015 Dec; 205(6):1360-4. PubMed ID: 26204111
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer survival among women under age 50: is mammography detrimental?
Stacey-Clear A; McCarthy KA; Hall DA; Pile-Spellman E; White G; Hulka C; Whitman GJ; Mahoney E; Kopans DB
Lancet; 1992 Oct; 340(8826):991-4. PubMed ID: 1357448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
